The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
University of California, San Francisco · UCSF Helen Diller Family Comprehensive Cancer Center · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
553
total citations
- FWCI
- 28.10
- Percentile
- 100%
- References
- 39
Citations per year
Authors
33- LLLuping LinCorresponding
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- AJAmit J. Sabnis
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- ECElton Chan
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- VOVictor Olivas
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- LCLindsay Cade
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
Topics & keywords
Keywords
- Effector
- Biology
- Hippo signaling pathway
- Cancer research
- MEK inhibitor
- Cancer
- MAPK/ERK pathway
- Cell biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.